David Fore, Executive Director, Lybba, Michael Seid, PhD Co-PI at C3N Cinncinati Children’s Hospital and Lesa Mitchell, VP Kauffman Foundation will share the ongoing lessons in the development of a project to enable a transparent network for patients/families and providers to improve health outcomes for Crohns patients. The project would accomplish the following:
The project would follow a phased approach to enable prototyping and rapid learning where prototypes/interventions are launched at a few clinical sites, adjusted based on experience, before being deployed to additional sites. The key set of activities include (1) the development of a technology backbone, (2) the engagement of an active physician/patient network, (3) the development of an Intellectual Property framework, and (4) the development of a standard cost assessment methodology in partnership with payers.
The solutions/interventions to be deployed in the project fall in the following two categories:
David Fore has been an interaction designer for more than 15 years. He is head of design Executive Director at Lybba, a nonprofit whose mission is to connect people with the community, information, and resources they need to care for themselves and one another. Lybba is one of the founding members of the Collaborative Chronic Care Network, an NIH-funded initiative based at Cincinatti Children’s hospital whose purpose is to create a learning-healthcare system that drives down costs, improves care.
Lesa Mitchell is a vice president with the Kauffman Foundation.
She has been responsible for the Foundation’s frontier work in understanding the policy levers that influence the advancement of innovation from universities into the commercial market and the new relationships between philanthropy and for profit companies. Under Mitchell’s leadership, the Foundation is defining and codifying alternative commercialization pathways, and identifying new models to foster innovation. Mitchell was instrumental in the founding of the Kauffman Innovation Network/ iBridge Network, the Translational Medicine Alliance, the National Academies-based University–Industry Partnership and leader in the replication of innovator-based mentor programs across the U.S. In addition, Mitchell serves on the boards of the Regenerative Medicine Foundation and the University of Kansas Institute for Commercialization.
Prior to joining Kauffman, Mitchell spent twenty years of her career in global executive roles at Aventis, Quintiles, and Marion Laboratories and ran an electronic clinical trials consulting business in support of global pharmaceutical clients.
Michael applies social and behavioral science to answer the question “What does it take to achieve the best outcomes possible for children with chronic health conditions?” He works at Cincinnati Children’s Hospital Medical Center and is Professor of Pediatrics at University of Cincinnati Medical School. He is co-Principal Investigator, with Peter Margolis, of the C3N Project, funded by a Transformative R01 grant from the NIH.
For information on exhibition and sponsorship opportunities at the conference, contact Sharon Pierce at (203) 304-9476 or firstname.lastname@example.org
For information on trade opportunities with O'Reilly conferences contact mediapartners
For media-related inquiries, contact Maureen Jennings at email@example.com
View a complete list of Strata Rx contacts